ÂÜÀòÂÒÂ×

Chris Boyle is an accomplished executive with extensive experience in the biotechnology and medical device sectors. As CEO of SOLOSHOT since January 2010, Chris has led innovative initiatives in technology. Prior to this role, Chris served as R&D Engineering Manager and Limited Partner at Advanced Bio Prosthetic Surfaces LLP and ABPS Venture One, LLP from December 1999 to February 2004. Additionally, Chris co-founded SoTex Medical, Inc. and founded Nitinol Research & Consulting, LLC in January 1999, focusing on the development of advanced medical devices and earning seven issued patents for pioneering work in superelastic Nickel Titanium alloys and percutaneous transluminal heart valves.